FDA Approves Expanded Indication For Medical Device To Treat A Form Of Brain Cancer
FDA approved an expanded indication for the Optune device to treat patients with newly-diagnosed glioblastoma multiforme (GBM), an aggressive form of brain cancer. It is given along with the chemotherapy drug temozolomide (TMZ) following standard treatments that include surgery, chemotherapy, and radiation therapy.
[su_button url=”http://links.govdelivery.com/track?type=click&enid=ZWFzPTEmbWFpbGluZ2lkPTIwMTUxMDA3LjQ5OTcwNzExJm1lc3NhZ2VpZD1NREItUFJELUJVTC0yMDE1MTAwNy40OTk3MDcxMSZkYXRhYmFzZWlkPTEwMDEmc2VyaWFsPTE3MjAxMTM4JmVtYWlsaWQ9RG9yb3RoeS5HcmVlbkBmbGFzY28ub3JnJnVzZXJpZD1Eb3JvdGh5LkdyZWVuQGZsYXNjby5vcmcmZmw9JmV4dHJhPU11bHRpdmFyaWF0ZUlkPSYmJg==&&&107&&&http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm465744.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery” target=”blank” style=”flat” background=”#ff002d” color=”#fafafa” size=”5″ center=”yes” icon=”icon: hand-o-right” icon_color=”#ffffff” text_shadow=”0px 0px 0px #fafafa”]Click Here For More Information![/su_button]
